These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12032102)

  • 1. Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study.
    Meigs JB; D'Agostino RB; Nathan DM; Rifai N; Wilson PW;
    Diabetes Care; 2002 Jun; 25(6):977-83. PubMed ID: 12032102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study.
    Meigs JB; Jacques PF; Selhub J; Singer DE; Nathan DM; Rifai N; D'Agostino RB; Wilson PW;
    Diabetes Care; 2001 Aug; 24(8):1403-10. PubMed ID: 11473077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.
    Arnlöv J; Evans JC; Meigs JB; Wang TJ; Fox CS; Levy D; Benjamin EJ; D'Agostino RB; Vasan RS
    Circulation; 2005 Aug; 112(7):969-75. PubMed ID: 16087792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study.
    Meigs JB; Nathan DM; D'Agostino RB; Wilson PW;
    Diabetes Care; 2002 Oct; 25(10):1845-50. PubMed ID: 12351489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
    Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects.
    Woo J; Cockram CS; Swaminathan R; Lau E; Chan A; Cheung R
    Int J Cardiol; 1992 Dec; 37(3):345-50. PubMed ID: 1468818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary albumin excretion at follow-up predicts cardiovascular outcomes in subjects with resistant hypertension.
    Oliveras A; Armario P; Sierra C; Arroyo JA; Hernández-del-Rey R; Vazquez S; Larrousse M; Sans L; Roca-Cusachs A; de la Sierra A
    Am J Hypertens; 2013 Sep; 26(9):1148-54. PubMed ID: 23747954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria: associations with height and sex in non-diabetic subjects.
    Gould MM; Mohamed-Ali V; Goubet SA; Yudkin JS; Haines AP
    BMJ; 1993 Jan; 306(6872):240-2. PubMed ID: 8443522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension.
    Pascual JM; Rodilla E; Gonzalez C; Pérez-Hoyos S; Redon J
    Hypertension; 2005 Jun; 45(6):1125-30. PubMed ID: 15897369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between urinary albumin creatinine ratio and cardiovascular disease.
    Kim YJ; Hwang SW; Lee T; Lee JY; Uh Y
    PLoS One; 2023; 18(3):e0283083. PubMed ID: 36943853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine Albumin/Creatinine Ratio Below 30 mg/g is a Predictor of Incident Hypertension and Cardiovascular Mortality.
    Sung KC; Ryu S; Lee JY; Lee SH; Cheong E; Hyun YY; Lee KB; Kim H; Byrne CD
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27625343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-normal blood pressure is associated with microalbuminuria in the general population: the Watari study.
    Munakata M; Konno S; Ohshima M; Ikeda T; Miura Y; Ito S
    Hypertens Res; 2011 Oct; 34(10):1135-40. PubMed ID: 21796135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study.
    Xu J; Knowler WC; Devereux RB; Yeh J; Umans JG; Begum M; Fabsitz RR; Lee ET
    Am J Kidney Dis; 2007 Feb; 49(2):208-16. PubMed ID: 17261423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-normal diastolic blood pressure is a risk for development of microalbuminuria in the general population: the Watari study.
    Konno S; Hozawa A; Miura Y; Ito S; Munakata M
    J Hypertens; 2013 Apr; 31(4):798-804. PubMed ID: 23340164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease.
    Marín R; Rodríguez P; Tranche S; Redón J; Morales-Olivas F; Galgo A; Brito MA; Mediavilla J; Lozano JV; Filozof C;
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S178-88. PubMed ID: 17130259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired fasting blood glucose is associated with incident albuminuria: Data from a Chinese community-based cohort.
    Jiang Y; Jia J; Li J; Huo Y; Fan F; Zhang Y
    J Diabetes Complications; 2022 Feb; 36(2):108125. PubMed ID: 35063343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of incident albuminuria in the Framingham Offspring cohort.
    O'Seaghdha CM; Hwang SJ; Upadhyay A; Meigs JB; Fox CS
    Am J Kidney Dis; 2010 Nov; 56(5):852-60. PubMed ID: 20599306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of microalbuminuria and relationship to the risk of cardiovascular disease in the Japanese population.
    Tomura S; Kawada K; Saito K; Lin YL; Endou K; Hirano C; Yanagi H; Tsuchiya S; Shiba K
    Am J Nephrol; 1999; 19(1):13-20. PubMed ID: 10085444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Absolute Risk for Cardiovascular Disease Stratified by Fasting Glucose Level.
    Bancks MP; Ning H; Allen NB; Bertoni AG; Carnethon MR; Correa A; Echouffo-Tcheugui JB; Lange LA; Lloyd-Jones DM; Wilkins JT
    Diabetes Care; 2019 Mar; 42(3):457-465. PubMed ID: 30617142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.